Trial · NCT07883122
Permanent Versus Slowly Dissolving Stitches for Non-Mesh (Shouldice) Groin Hernia Repair
NCT07883122, Not applicable, Recruiting, Northwestern University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Permanent Versus Slowly Dissolving Stitches for Non-Mesh (Shouldice) Groin Hernia Repair. Trials, record NCT07883122. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883122
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Permanent Versus Slowly Dissolving Stitches for Non-Mesh (Shouldice) Groin Hernia Repair
- NCT number
- NCT07883122
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Northwestern University
- Conditions
- Inguinal Hernia
- Interventions
- Polypropylene suture (Prolene), Polydioxanone suture (PDS)
- First posted
- 2026-10-20
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants with Inguinal Hernia Recurrence | 1 year (+/- 2 months) after surgery | Recurrent inguinal hernia identified on clinical examination and confirmed by imaging. |
| Secondary | Postoperative Complications (wound complications, readmissions, reoperations) | 30 days (+/- 15 days) and 1 year (+/- 2 months) after surgery | Postoperative complications, including wound complications, readmissions, and reoperations. |
| Secondary | EuraHS-QoL (European Registry for Abdominal Wall Hernias Quality of Life) Total Score | Baseline (preoperative), 30 days, 6 months, and 12 months after surgery | Patient-reported quality of life measured with the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) score. The total score ranges from 0 to 90; higher scores indicate worse quality of life. |
| Secondary | EuraHS-QoL Pain Domain Score | 6 and 12 months after surgery | Groin pain measured with the pain domain of the EuraHS-QoL questionnaire (3 items). The domain score ranges from 0 to 30; higher scores indicate worse pain. |
| Secondary | Number of Participants Reporting Foreign Body Sensation | 30 days, 6 months, and 12 months after surgery | Number of participants reporting a foreign body sensation in the groin, assessed with a single yes/no question. |
| Secondary | Number of Participants Who Believe They Received Permanent Suture | 30 days, 6 months, and 12 months after surgery | Participants are asked which suture type they believe was used in their repair. |
| Secondary | Enrollment Rate | From study start through end of enrollment, approximately 12 months | Mean number of participants randomized per month of active enrollment, from first to last randomization. |
| Secondary | Number of Participants Receiving the Allocated Suture Repair | Day of surgery | Number of randomized participants whose Shouldice repair was completed using the allocated suture (Prolene or PDS) in all four layers. |
| Secondary | Number of Participants Completing the 12-Month Recurrence Assessment and All Scheduled EuraHS-QoL Questionnaires | 12 months after surgery (+/- 2 months) | Each participant is classified as having complete or incomplete follow-up. Complete follow-up requires both attendance at the 12-month visit with a hernia recurrence assessment and completion of the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) questionnaire at 30 days, 6 months, and 12 months. The total score for the EuraHS-QoL ranges from 0 to 90; higher scores indicate worse quality of life. The number of participants with complete follow-up is reported. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883122
GET https://conductscience.org/api/trials/v1/NCT07883122/registered